Author

Melissa Durkin

Observed name: Melissa R. Durkin

Institution: Adimab (United States)

Observed institution: Adimab (United States)

ORCID: 0000-0001-6886-2203

Observed ORCID: 0000-0001-6886-2203

OpenAlex ID: A5031929455

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

2021 · Shira Weingarten-Gabbay, Susan Klaeger, et al. · Cell · 176

Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposure

2021 · Joshua M. Francis, Del Leistritz-Edwards, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 90

1024 Rapid and efficient generation of format-diverse co-stimulatory CD28 and CD3 multispecific antibody panels for T cell engagement via complementary technologies

2025 · Nathan Sharkey, Cory Ahonen, et al. · Journal for ImmunoTherapy of Cancer

Abstract 5792: Rapid and efficient generation of panels of T cell engaging (TCE) multispecific antibodies via complementary technologies

2024 · Cory Ahonen, Nathan Sharkey, et al. · Cancer Research

Works count: 4

Citation count: 266

H-index: 2

I10-index: 2